# AIVF

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aivf

- Industry: Healthcare IT
- Headquarters: Tel Aviv, Israel
- Website: www.aivf.co
- Total disclosed funding: $25M
- Latest round: Series A (Jun 22, 2022)
- Investors on record: 2

## About

Based in Tel Aviv, Israel, and founded in 2018 by its CEO Daniella Gilboa and co-founder Prof. Daniel Seidman, AIVF Ltd. operates as a developer of medical technology artificial intelligence programs that help patients with their fertility stage. In June 2022, AIVF Ltd. raised USD 25 million in series A funding led by new investor Insight Partners, with participation from another new investor 166 2nd Financial Services. Individual investors and other unspecified investors also participated in the round.

AIVF Ltd. offers software as a service-based platform that provides an optimized end-to-end IVF option for individuals by using artificial intelligence (AI) technology to assist embryo evaluation and support operational efficiencies in IVF clinics. Its machine learning and computer vision algorithms shorten the time to pregnancy and increase IVF predictability. The company partners with clinics to advance research and innovation in reproductive medicine.

The company plans to use the funding for research and development of digital fertility care, hire new members as well as introduce its AI platform EMA across the US and Europe.

## Funding rounds

- Series A, Jun 22, 2022, $25M — Insight Partners, 166 2nd Financial Services

## Investors

- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series A
- 166 2nd Financial Services — Series A